Financhill
Back

Black Diamond Therapeutics, Inc. Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Black Diamond Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 3.49 Sell
20-day SMA: 3.88 Sell
50-day SMA: 3.87 Sell
200-day SMA: 2.69 Buy
8-day EMA: 3.35 Sell
20-day EMA: 3.67 Sell
50-day EMA: 3.7 Sell
200-day EMA: 3.17 Sell

Black Diamond Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 26.77 Sell
Chaikin Money Flow: 2291656 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.41 - 4.33) Sell
Bollinger Bands (100): (2.83 - 3.97) Sell

Black Diamond Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Black Diamond Therapeutics, Inc. Stock

Is Black Diamond Therapeutics, Inc. Stock a Buy?

BDTX Technical Analysis vs Fundamental Analysis

Sell
2
Black Diamond Therapeutics, Inc. (BDTX) is a Sell

Is Black Diamond Therapeutics, Inc. a Buy or a Sell?

Black Diamond Therapeutics, Inc. Stock Info

Market Cap:
154.4M
Price in USD:
2.71
Share Volume:
2.5M

Black Diamond Therapeutics, Inc. 52-Week Range

52-Week High:
4.94
52-Week Low:
1.20
Sell
2
Black Diamond Therapeutics, Inc. (BDTX) is a Sell

Black Diamond Therapeutics, Inc. Share Price Forecast

Is Black Diamond Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Black Diamond Therapeutics, Inc.

Is Black Diamond Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.69 per share, and a decrease next year of $1.02 per share.

Technical Analysis of Black Diamond Therapeutics, Inc.

Should I short Black Diamond Therapeutics, Inc. stock?

* Black Diamond Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.